drugset

drugset / Trial / NCT00439062

Treatment of Rheumatoid Arthritis With Roxithromycin

NCT00439062 ↗

Phase 4 Completed 100 enrolled Nazilli State Hospital

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the clinical efficacy, safety, and tolerability of roxithromycin in patients with rheumatoid arthritis.

Timeline

Start: 2006-06
Primary completion: —
Completion: 2006-06

Publications

Ogrendik M, Karagoz N. Treatment of rheumatoid arthritis with roxithromycin: a randomized trial. Postgrad Med. 2011 Sep;123(5):220-7. doi: 10.3810/pgm.2011.09.2478.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	roxithromycin	Small molecule	300 mg	Oral

Indications